Evaluating the impact of Halotherapy on improving pulmonary tests results and status of patients with Chronic Obstructive Pulmonary Disease referred to Dr. Masih Daneshvary hospital of Tehran in 2016 to 2017
Phase 3
- Conditions
- Chronic obstructive pulmonary disease.Chronic obstructive: airway disease NOS lung disease NOS
- Registration Number
- IRCT2016080927995N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
COPD patients regarding GOLD criteria; Stable patients older 18 years . Exclusion criteria: History of surgery in thorax; COPD exacerbation; Unbearable complications of COPD; Huge changes in treatment regimen; Missing patients through out the study; Irregular treatment; Smoking; Exacerbation in comorbidities like CHF, CRF, etc.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The walked distance. Timepoint: two month after first visit. Method of measurement: 6MWT.;Forced vital capacity. Timepoint: two month after study beginning. Method of measurement: spirometry.;Forced expiratory volume. Timepoint: two month after study beginning. Method of measurement: spirometry.;Minute. Timepoint: 2 month after first visit. Method of measurement: 6MWD.
- Secondary Outcome Measures
Name Time Method Disease manifestation. Timepoint: 2 month after first visit. Method of measurement: Asking patients.;Exacerbation rate. Timepoint: Every other month. Method of measurement: Asking patients.